Knowledge Distillery

The aim of this retrospective, international multicenter study was to assess the association between abnormal findings on chest and brain imaging in…

The purpose of this review was to provide an overview on current knowledge of neurological symptoms and complications of COVID-19, and to suggest…

Studies suggest an increased risk of adverse outcomes among patients with acute ischemic stroke (AIS) and COVID-19.

The objective of this matched cohort study was to establish whether there is any change in mortality from infection with a new variant of SARS-CoV-2 ,…

Most human monoclonal antibodies (mAbs) neutralizing SARS-CoV-2 recognize the spike (S) protein receptor-binding domain and block virus interactions…

SARS-CoV-2 has currently precipitated the COVID-19 global health crisis. The authors of this article developed a medium-throughput drug screening…

COVID-19 pandemic is the third zoonotic coronavirus (CoV) outbreak of the century after SARS in 2003 and MERS since 2012.

COVID-19 affects the nervous system in adult patients. The spectrum of neurologic involvement in children and adolescents is unclear. The objective …

Refinement of criteria for multisystem inflammatory syndrome in children (MIS-C) may inform efforts to improve health outcomes.

There is evidence of central nervous system impairments associated with COVID-19 infection, including encephalopathy.

The objective of this article was to assess clinical outcomes with convalescent plasma treatment vs placebo or standard of care in peer-reviewed and…

SARS-CoV-2 lineage B.1.1.7, a variant first detected in the UK in September 2020, has spread to multiple countries worldwide.